Daiichi Sankyo (Germany)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (Germany), Germany, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
57%
Total
Publications
1.3K
Total Open
Publications
739
Total
Citations
35K
Open Access
Percentage
57%
Total
Publications
1.3K
Total Open
Publications
739
Total
Citations
35K
Breakdown
Publisher Open
36%
Both
17%
Other Platform Open
3%
Closed
44%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 22%
150
Hybrid 31%
213
No Guarantees 47%
330
Other Platform Open
Domain 77%
198
Institution 33%
84
Other Internet 17%
45
Public 1%
3
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 200 |
DOI | Other Internet | 30 |
DANS - Data Archiving and Networked Services | Institution | 24 |
Elsevier - Scopus | Institution | 16 |
Unknown Repository | Other Internet | 14 |
Europe PMC | Domain | 9 |
University of Modena and Reggio Emilia - IRIS UNIMORE | Institution | 7 |
universiteitleiden.nl OAI-PMH Repository | Institution | 7 |
University of Zurich - Zurich Open Repository and Archive | Institution | 5 |
University of Pisa - CINECA IRIS Institutial research information system | Institution | 5 |